Jantzen Beth 4
4 · APPLIED DNA SCIENCES INC · Filed Dec 12, 2018
Insider Transaction Report
Form 4
Jantzen Beth
Chief Financial Officer
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2018-12-10−4,167→ 0 totalExercise: $8.16Exp: 2018-12-10→ Common Stock (4,167 underlying) - Award
Stock Option (right to buy)
2018-12-10+4,167→ 4,167 totalExercise: $8.16From: 2018-12-10Exp: 2023-12-09→ Common Stock (4,167 underlying)
Footnotes (1)
- [F1]The two reported transactions involve an amendment of an outstanding option to extend the expiration date of such option from December 10, 2018 to December 09, 2023, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on December 10, 2013 and provided for immediate vesting.